Standout Papers
Citation Impact
Citing Papers
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society
1997
Omalizumab for asthma in adults and children
2014
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults: Fig 1
1996
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations
2015
The Nuclear Factor NF- B Pathway in Inflammation
2009 Standout
Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma
1998
Consensus statement * on the treatment of allergic rhinitis
2000
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
High-dose Inhaled Albuterol in Severe Chronic Airflow Limitation
1988
Fluticasone propionate: topical or systemic effects?
1996
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
2005
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
2004
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
1996
Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.
1996
Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
1998
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Intranasal Fluticasone Propionate
1992
Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
1995
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
1995
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids
2005
A double‐blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen
1994
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Nasal cytology in patients with allergic rhinitis: Effects of intranasal fluticasone propionate
1994
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Mucosal IgA and URTI in American College Football Players: A Year Longitudinal Study
2005
One Airway, One Disease
1997
Novel IgE peptide‐based vaccine prevents the increase of IgE and down‐regulates elevated IgE in rodents
2007
Comparison of Once Daily Mometasone Furoate (Nasonex) and Fluticasone Propionate Aqueous Nasal Sprays for the Treatment of Perennial Rhinitis
1997
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model
1994
Update on optimal use of omalizumab in management of asthma
2011
IgE and mast cells in allergic disease
2012 Standout
Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal–axis activity
1998
Intranasal Fluticasone Propionate Is More Effective Than Terfenadine Tablets for Seasonal Allergic Rhinitis
1994
β-Adrenergic Bronchodilators
1995
Heat Stroke
2002 Standout
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
2011
Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily
1992
In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise
1997
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators
1998
Effects of antihistamines in adult asthma: a meta-analysis of clinical trials
1997
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis
1996
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Asthma: defining of the persistent adult phenotypes
2006
Asthma
2017 Standout
A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler
1997
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐ and placebo‐controlled study
1996
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
1999
Effects of montelukast and beclomethasone on airway function and asthma control
2002
Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
1998
Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis
1998
Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma
1994
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2014
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis
1995
Use of nasal steroids in managing allergic rhinitis
1999
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
The development of allergic inflammation
2008 StandoutNature
Add‐on omalizumab improves day‐to‐day symptoms in inadequately controlled severe persistent allergic asthma
2008
Circadian control of the immune system
2013 Standout
Asthma
2001 Standout
Fluticasone at different doses for chronic asthma in adults and children
2005
Anti-IgE as a mast cell–stabilizing therapeutic agent
2006
The antihistamines of the nineties
1993
Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses
1996
How were new medicines discovered?
2011 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Severe asthma treatment: need for characterising patients
2005
Quality of life changes in COPD patients treated with salmeterol.
1997
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis☆☆☆★★★♢
1998
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Fluticasone Propionate Aqueous Nasal Spray Treatment for Perennial Allergic Rhinitis in Children
1997
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis
1996
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
The ??2-Agonist Controversy
1994
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis
1996
Nasal cytological changes following pharmacological intervention
1995
New developments in FcεRI regulation, function and inhibition
2007
Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease
2004
Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis
1996
Safety and Efficacy of Azelastine Nasal Spray (Astelin NS) for Seasonal Allergic Rhinitis: a 4-Week Comparative Multicenter Trial
1996
Fluticasone propionate aqueous nasal spray: a well‐tolerated and effective treatment for children with perennial rhinitis
1996
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
2004
Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma
1996
Risk-Benefit Assessment of Fluticasone Propionate in the Treatment of Asthma and Allergic Rhinitis
1998
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
1994
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects
1996
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Anti‐immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti‐inflammatory activity and clinical efficacy
2005
Saliva Composition and Exercise
1998
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
1998 Standout
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Exploring the Effects of Omalizumab in Allergic Asthma
2013
Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma
2004
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Asthma
2005
Choosing a Long-term Controller Medication in Childhood Asthma
1997
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
The chromones: history, chemistry and clinical development. A tribute to the work of Dr R. E. C. Altounyan
2000
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
2004
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
2011
Exercise and the Immune System: Regulation, Integration, and Adaptation
2000
Long- and Short-Acting ß2-Adrenergic Agonists
1996
24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol
2009
Long‐term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis
1999
Guidelines for the Primary Prevention of Stroke
2014 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials
2000
Position statement. Part one: Immune function and exercise.
2011
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Immunotherapy as an effective tool in allergy treatment
1998
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Acute and chronic effects of exercise on markers of mucosal immunity
2009
A Comparison of Aqueous Suspensions of Budesonide Nasal Spray (128 μg and 256 μg Once Daily) and Fluticasone Propionate Nasal Spray (200 μg Once Daily) in the Treatment of Adult Patients with Seasonal Allergic Rhinitis
1997
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Fluticasone at different doses for chronic asthma in adults and children
2008
The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis
1998
Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
1994
Infectious episodes in runners before and after the Los Angeles Marathon.
1990
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
1997
Immune response to heavy exertion
1997
The anti-inflammatory effect of exercise
2005 Standout
Intranasal Fluticasone Propionate
1997
The role of leukotrienes in asthma and allergic rhinitis
1996
Works of Andre van As being referenced
Intranasal Fluticasone Propionate Is Effective and Well-Tolerated in Adolescents with Seasonal Allergic Rhinitis
1994
Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.
1991
A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
1992
Evaluation of the Safety and Efficacy of Multiple Doses of Azelastine to Adult Patients with Bronchial Asthma over Time
1990
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
2001 Standout
The Effect of Exercise on Secretory and Natural Immunity
1987
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
1994
A Comparative Study of the Clinical Efficacy of Nedocromil Sodium and Placebo
1996
Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study
2007
A 1-Week Dose-Ranging Study of Inhaled Salmeterol in Patients With Asthma
1994
Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
1994
Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma
2007
Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate
1993
Decreased secretory immunoglobulins following intense endurance exercise
1989
Comparison of inhaled albuterol powder and aerosol in asthma
1987
DECREASED LEVELS OF SECRETORY IMMUNOGLOBULINS FOLLOWING PROLONGED EXERCISE
1986
Once- versus Twice-Daily Fluticasone Propionate Aqueous Nasal Spray for Seasonal Allergic Rhinitis
1993